Aytu Bioscience, Inc.

AYTU US0547548588

🆔
Registration No.
5759344
💰
Capitalization
Small-cap

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

🔗
Website
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
4
🙍
Insiders
2
Person Price Shares Total Published Completed
Disbrow Joshua R.
CEO 		1.50
USD 		66,666
Bought 		99,999
USD 		09/06/2025 09/06/2025
Disbrow Jarrett
CBO 		1.50
USD 		16,666
Bought 		24,999
USD 		09/06/2025 09/06/2025
Disbrow Jarrett
CBO 		1.50
USD 		16,666
Bought 		24,999
USD 		09/06/2025 09/06/2025
Disbrow Joshua R.
CEO 		1.30
USD 		15,000
Bought 		19,500
USD 		28/02/2025 28/02/2025
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Aytu Bioscience, Inc. to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Disbrow Joshua R. 2 119,499.00 59,749.50 28/02/2025 09/06/2025
Disbrow Jarrett 2 49,998.00 24,999.00 09/06/2025 09/06/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
Zynex, Inc. Common Stock US98986M1036 ZYXI

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.